BecauseIKnow
Rookie
- Aug 5, 2012
- 11,294
- 439
- 0
- Banned
- #61
Yet you still have yet to disprove those things were never said......
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Nah, he used two websites. The "mona" website he took the Zionist quotes and he broke that up into 6 posts. Check it out. Why are you providing cover for trolling and lying? Do you understand what "main domain" and subdomain mean? The Zionist quotes was subdomain of the mona islamist garbage website which claims a genocide in Gaza. All those individual quotes he got from the "Zionist quotes" page from the Mona site. Even a 3rd grader with basic rudimentary Internet knowledge knows this.Donkey boy, your illiteracy has already been established, go to the homepage of that garbage site Mona Baker - Home Page
And you will see the "genocide in Gaza" lie being promoted. Apparently this site has the stamp of approval from all the IslamoNazi terrorist groups, Hamas, Al Queda, and Hezbollah. But thanks for pointing it out as another site for DHS to keep an eye on.
If you go back to that post you will see it was edited by one of the moderators because BiK did not supply a link for the quote (copyright violation). Usually, we try to be curteous and search for a link and add it in. That does not mean it was the link that BiK originally got it from. If he used a different source, he can supply it and I'll update the post.
And now he's using "what really happened" as his second source, which is a 9-11 truther nutjob conspiracy site. So I don't know which is worse?!
You are really destroying your credibility when you cover for an ignorant illiterate like BecauseKnowsJackshit. Up to you. You know what they say about lying with dogs...
HIV drugs called nucleoside reverse transcriptase inhibitors (NRTIs), including AZT and three others, blocked age-related macular degeneration in mice and worked well in experiments involving human retinal cells in the laboratory, researchers said Thursday. In HIV-infected people, NRTIs block an enzyme the virus uses to create more copies of itself. The new research shows the drugs also block the activity of a biological pathway responsible for activating inflammatory processes in the body. It is that previously unrecognized quality that makes NRTIs promising for treating macular degeneration as well as graft-versus-host disease, a rarer ailment that can occur after a stem cell or bone marrow transplant, the researchers said.
'Like an epidemic'
University of Kentucky ophthalmologist Dr. Jayakrishna Ambati, who led the study published in the journal Science, said macular generation affects an estimated 50 million people worldwide. "With the aging of the population, it is projected to affect 200 million people by the year 2020," Ambati said. "It is therefore critical that we develop new and improved treatments for this disease, which is growing like an epidemic." Macular degeneration causes cells to die in the macula, a part of the eye located near the center of the retina that permits vision in fine detail.
Gloria Thompson, 68, receives an eye exam at the Care Harbor/LA free clinic in Los Angeles
The chronic disease has two forms: "dry" and "wet." Several treatments exist for "wet" macular degeneration but only about a third of patients get significant vision improvement. There are no approved treatments for the "dry" form, which is much more common but less severe. The "wet" type occurs when abnormal blood vessels grow under the macula and leak blood and fluid. The "dry" form occurs when cells in the macula break down.
Damaging proteins blocked
In the new study, the NRTIs blocked a powerful collection of proteins that can kill cells in the retina, preserving vision in mice. Researchers are planning for clinical trials in the coming months, and it could be known in as soon as two to three years whether the drugs are effective in treating macular degeneration in people, Ambati said. Because these inexpensive drugs are already approved by the U.S. Food and Drug Administration and have a good safety record, they could be "repurposed" rapidly to treat other illnesses, he added.
HIV Drugs Show Promise in Treating Common Eye Disease